Travere Therapeutics Inc. (TVTX)
NASDAQ: TVTX
· Real-Time Price · USD
18.72
0.49 (2.69%)
At close: Aug 15, 2025, 12:49 PM
Travere Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 333.87M | 273.53M | 233.18M | 203.45M | 177.64M | 183.22M | 198.84M | 209.65M | 226.05M | 220.52M | 212.02M | 213.4M | 228.12M | 228.57M | 227.49M | 221.22M | 204.15M | 197.96M |
Cost of Revenue | 8.86M | 21.26M | 18.09M | 31.95M | 31.61M | 21.2M | 24.82M | 10.13M | 10.52M | 10.58M | 7.59M | 7.76M | 7.68M | 7.28M | 6.78M | 6.96M | 6.56M | 6.4M |
Gross Profit | 309.47M | 252.27M | 215.09M | 171.5M | 146.03M | 162.03M | 174.02M | 199.52M | 215.54M | 209.94M | 204.43M | 205.64M | 220.44M | 221.29M | 220.71M | 214.26M | 197.59M | 191.56M |
Operating Income | -169.47M | -223.77M | -321.78M | -343.88M | -378.37M | -398.9M | -339.95M | -326.12M | -301.84M | -279.71M | -256.47M | -234.65M | -201.4M | -171.27M | -161.76M | -233.13M | -220.85M | -208.65M |
Interest Income | 14.45M | 15.58M | 17.82M | 21.17M | 23.45M | 24.15M | 21.77M | 17.73M | 13.99M | 9.64M | 6.28M | 3.4M | 1.66M | 1.86M | 1.99M | 2.35M | 3.11M | 3.44M |
Pretax Income | -169.1M | -225.93M | -320.51M | -348.7M | -383.09M | -399.09M | -349.57M | -326.81M | -307.09M | -288.5M | -278.17M | -263.98M | -230.06M | -202.05M | -179.68M | -250.21M | -237.14M | -224.18M |
Net Income | -169.06M | -226.71M | -321.55M | -351.45M | -145.91M | -161.13M | -111.4M | -87.05M | -307.44M | -288.84M | -278.48M | -264.23M | -230.22M | -202.19M | -180.09M | -250.14M | -237.05M | -224.11M |
Selling & General & Admin | 284.17M | 262.39M | 253.77M | 237.01M | 239.19M | 258.79M | 266.82M | 277M | 266.72M | 245.66M | 220.21M | 199.36M | 177.91M | 159.89M | 149.88M | 143.55M | 139.43M | 139.44M |
Research & Development | 210M | 214.97M | 282.7M | 279.38M | 288.29M | 303.38M | 248.66M | 250.15M | 248.81M | 239.08M | 235.78M | 237.72M | 226.87M | 218.99M | 210.33M | 186.54M | 170.49M | 149.47M |
Other Expenses | 1.64M | 123K | 361K | 361K | 1.53M | 1.33M | 1.18M | 2.05M | 172K | 1.03M | 974K | 556K | 1.8M | 1.35M | 1.32M | 1.5M | 1.4M | 1.61M |
Operating Expenses | 497.22M | 478.88M | 538M | 516.51M | 528.77M | 563.46M | 516.77M | 528.44M | 515.53M | 484.75M | 455.99M | 437.08M | 404.77M | 378.89M | 360.21M | 326.3M | 306.13M | 285.11M |
Interest Expense | 5.61M | 11.24M | 11.18M | 11.19M | 11.23M | 11.29M | 11.34M | 11.41M | 11.42M | 11.55M | 11.21M | 13.38M | 15.46M | 17.34M | 20.14M | 19.83M | 19.7M | 19.48M |
Selling & Marketing Expenses | n/a | -10.35M | -10.35M | -21.2M | -21.2M | -10.86M | -4.56M | 6.29M | 11.39M | 11.39M | 5.1M | 5.1M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 378.85M | 500.02M | 555.97M | 548.34M | 559.1M | 583.37M | 540.3M | 537.28M | 526.05M | 495.32M | 463.58M | 444.84M | 412.45M | 386.16M | 367M | 333.26M | 312.68M | 291.51M |
Income Tax Expense | -137K | -32K | 120K | 260K | 332K | 312K | 199K | 194K | 351K | 339K | 313K | 254K | 152K | 148K | 409K | -66K | -86K | -70K |
Shares Outstanding (Basic) | 88.95M | 88.36M | 83.11M | 77.78M | 77.5M | 77.14M | 76.47M | 76.31M | 76M | 68.17M | 64.21M | 64.03M | 63.64M | 63.13M | 61.62M | 60.41M | 60.57M | 56.27M |
Shares Outstanding (Diluted) | 88.95M | 88.36M | 83.11M | 77.78M | 77.5M | 77.14M | 76.47M | 76.31M | 76M | 68.17M | 64.21M | 64.03M | 63.64M | 63.13M | 61.62M | 60.8M | 60.57M | 56.27M |
EPS (Basic) | -2.04 | -2.81 | -4.1 | -4.55 | -4.84 | -5.06 | -4.57 | -4.42 | -4.52 | -4.44 | -4.37 | -4.18 | -3.68 | -3.27 | -3.03 | -4.56 | -4.41 | -4.35 |
EPS (Diluted) | -2.04 | -2.81 | -4.1 | -4.55 | -4.84 | -5.06 | -4.57 | -4.42 | -4.52 | -4.44 | -4.37 | -4.18 | -3.68 | -3.27 | -3.03 | -4.56 | -4.41 | -4.35 |
EBITDA | -124.53M | -168.21M | -265.77M | -294.2M | -328.31M | -364.88M | -332.54M | -312.25M | -311.34M | -274.24M | -249.8M | -235.68M | -184.47M | -156.07M | -131.91M | -203.17M | -191.67M | -179.69M |
EBIT | -160.56M | -214.69M | -309.33M | -337.51M | -371.86M | -404.11M | -364.77M | -341.93M | -336.61M | -301.6M | -281.36M | -265M | -214.61M | -184.71M | -159.54M | -230.37M | -217.43M | -204.69M |
Depreciation & Amortization | 36.13M | 46.48M | 43.56M | 43.32M | 43.55M | 47.11M | 46.78M | 44.23M | 41.33M | 35.53M | 33.08M | 30.84M | 30.13M | 28.65M | 27.63M | 27.2M | 25.77M | 25M |